BioSIS for Hernia Repair: The Biologic Alternative Veterinary Surgeons Need to Know

A 4-year-old Labrador Retriever presents for a routine wellness exam. On abdominal palpation, you notice a soft, reducible swelling in the inguinal region. The diagnosis is straightforward: inguinal hernia. The harder question is what to use for repair.

For decades, veterinary surgeons reached for polypropylene mesh as the default solution for soft tissue defects and hernia repair. It’s familiar. It’s available. But it’s also permanent — a foreign material that the body must wall off rather than remodel. In an era of regenerative medicine, that tradeoff deserves a second look.

Porcine small intestinal submucosa (SIS), the biological scaffold material in Vetrix BioSIS ECM, offers a fundamentally different approach: a material that communicates with the body, supports healing, and completely resorbs — leaving behind only organized, healthy tissue.

Why Synthetic Mesh Falls Short in Veterinary Hernia Repair

Polypropylene mesh has real advantages — it’s strong, well-studied, and widely available. But its limitations are equally well-documented. As a permanent synthetic material, mesh remains in the patient indefinitely, creating a chronic foreign body environment that carries ongoing risk.

Known complications of synthetic mesh in hernia repair include:

• Chronic inflammation and foreign body reaction
• Seroma formation at the implant site
• Infection risk, particularly in contaminated fields
• Fibrotic encapsulation rather than true tissue integration
• Migration or erosion into adjacent structures over time

In veterinary patients — particularly dogs and cats who are active, difficult to restrict post-operatively, and who may present with hernias in contaminated or compromised tissue fields — these risks are clinically meaningful. A material that the body can remodel into native tissue is not just a theoretical advantage. It’s a practical one.

How BioSIS Works: Signaling, Remodeling, and Resorption

Vetrix BioSIS ECM is derived from porcine small intestinal submucosa — an acellular extracellular matrix composed primarily of type I collagen and containing bioactive growth factors including vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF).

Unlike synthetic materials, BioSIS does not simply occupy space. It communicates with the patient’s biology through a four-stage process:

Signaling: BioSIS communicates with the body, signaling marrow-derived stem cells to differentiate into site-specific tissue. Rather than triggering a foreign body response, it recruits the patient’s own regenerative machinery.

Resistance to infection: BioSIS facilitates angiogenesis and rapidly remodels into vascularized tissue, enabling the body’s natural defense mechanisms to respond to potential infection. This is a meaningful advantage in contaminated surgical fields where synthetic mesh carries elevated infection risk.

Complete remodeling: During the remodeling process, BioSIS is replaced by the body’s native tissue — completely resorbing into the body, leaving behind only organized, healthy tissue. No permanent foreign material remains.

Long-term strength: BioSIS maintains the structural support needed to replicate the patient’s natural movement and function until proper tissue has been restored. It holds sutures, supports weakened tissue, and provides the mechanical integrity the repair requires.

Clinical Evidence: BioSIS in Veterinary Hernia Repair

The clinical evidence for porcine SIS in veterinary hernia repair is growing. A 2024 case report published in PMC documented the successful use of porcine small intestinal submucosa to repair a large congenital pleuroperitoneal hernia in a kitten — a defect that would have been technically challenging with synthetic materials. At 12-week follow-up, the patient was doing well both clinically and radiographically, with the SIS demonstrating effective integration and tissue support.

Earlier research established the use of porcine SIS for perineal herniorrhaphy in dogs, with results suggesting SIS may perform favorably compared to traditional repair techniques including internal obturator muscle transposition. Across multiple soft tissue applications, SIS consistently demonstrates its key advantage: the ability to support healing and then disappear, leaving the repair site indistinguishable from surrounding native tissue.

Dr. Kevin Benjamino, DVM, DACVS at Affiliated Veterinary Specialists, summarized the clinical utility directly:

“Vetrix SIS ECM is an integral part of any veterinary surgeon’s arsenal. I have used ECM for multiple soft tissue indications — body wall reconstruction, perineal hernia repairs, and urogenital surgery — with great success.”

When to Choose BioSIS for Hernia Repair

BioSIS is appropriate across a broad range of hernia repair indications in small and large animal patients. Clinical scenarios where BioSIS offers particular advantages include:

Contaminated or potentially infected fields: When operating in a field with elevated infection risk, the angiogenic properties of BioSIS and its ability to rapidly vascularize give it a meaningful edge over synthetic mesh.

Pediatric or young patients: In growing animals, permanent synthetic materials create long-term unknowns. BioSIS resorbs completely as native tissue develops, making it well-suited for congenital defect repair in young patients.

Body wall and thoracic defects: For thoracic wall repair and body wall reconstruction where tissue quality may be compromised, BioSIS provides the structural support needed during healing without leaving permanent foreign material in the thoracic cavity.

Perineal hernia repair: A well-established application where BioSIS has been used successfully as an alternative to traditional repair techniques.

Recurrent hernias: In cases where a previous repair has failed, introducing a synthetic material into an already-compromised tissue environment carries added risk. BioSIS’s resorbable, biocompatible nature makes it a rational choice for revision cases.

Gastrointestinal soft tissue repair: BioSIS is indicated for GI soft tissue repair including body wall closure following intestinal surgery.

Product Options and Practical Considerations

Vetrix BioSIS is available in multiple configurations to match the surgical indication:

• BioSIS Bioscaffold 4cm x 7cm (Multi-Layer) — for smaller defects
• BioSIS Bioscaffold 7cm x 10cm (Multi-Layer) — for larger body wall and thoracic defects
• BioSIS Bioscaffold 7cm x 10cm (Single Layer) — for applications requiring thinner profile

Each graft is individually sterilized and ready for implantation. BioSIS holds sutures reliably, can be trimmed to fit the defect, and handles similarly to other biological graft materials. The learning curve for surgeons familiar with soft tissue repair is minimal.

Post-operative management follows standard soft tissue repair protocols. Activity restriction during the initial healing phase allows the scaffold to begin remodeling before the patient returns to full function.

The Clinical Bottom Line

Hernia repair is one of the most common soft tissue procedures in veterinary surgery. The choice of repair material has real consequences — for healing, for infection risk, for the patient’s long-term quality of life, and for client satisfaction with the outcome.

BioSIS offers a biologically sound alternative to permanent synthetic mesh: a scaffold that supports the repair, recruits the body’s own regenerative capacity, and ultimately makes itself unnecessary — leaving behind only the tissue it helped build.

For veterinary surgeons looking to expand their regenerative medicine toolkit, BioSIS is a practical, evidence-supported starting point.

Ready to add BioSIS to your surgical practice?
Learn more about BioSIS ECM →

Contact us: 888-595-0170 | CustomerService@RethinkHealing.com